Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis  N. Horita, Y. Shibata, H.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital 
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and.
Benchmarking inappropriate empirical antibiotic treatment
Defining an extended-spectrum β-lactamase
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Migrant health—a cause for concern?
Defining an extended-spectrum β-lactamase
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Refugee crisis and re-emergence of forgotten infections in Europe
Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study  Y. Tagashira,
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital 
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
Louis Pasteur, from crystals of life to vaccination
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Vector control: a cornerstone in the malaria elimination campaign
Systematic review or meta-analysis
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with.
Training for the infectious diseases speciality in Norway
Isospora belli Clinical Microbiology and Infection
Laboratory diagnosis and biosafety issues of biological warfare agents
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Sepsis and neutropenia induced by clozapine
Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis  J.-W. Yang, L.-C. Fan, X.-Y. Miao, B.
A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics  J. Moira Greenhalgh,
Human infection with H9N2 avian influenza in northern China
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
Previously unknown species of Aspergillus
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Benchmarking inappropriate empirical antibiotic treatment
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Vaccinations against respiratory tract infections at Hajj
Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
W. Eugene Sanders, Christine C. Sanders 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis  N. Horita, Y. Shibata, H. Watanabe, H. Namkoong, T. Kaneko  Clinical Microbiology and Infection  Volume 23, Issue 10, Pages 723-729 (October 2017) DOI: 10.1016/j.cmi.2017.03.024 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Network plot for treatment success. Abbreviations: C/S, cefoperazone/sulbactam; CAZ, ceftazidime; CFPM, cefepime; CZOP, cefozopran; I/C, imipenem/cilastatin; MEPM, meropenem P/B, panipenem/betamipron; P/T, piperacillin/tazobactam. Clinical Microbiology and Infection 2017 23, 723-729DOI: (10.1016/j.cmi.2017.03.024) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Forest plots for key findings. Abbreviations: C/S, cefoperazone/sulbactam; CAZ, ceftazidime; CFPM, cefepime; CZOP, cefozopran; I/C, imipenem/cilastatin; MEPM, meropenem P/B, panipenem/betamipron; P/T, piperacillin/tazobactam; OR, odds ratio. Clinical Microbiology and Infection 2017 23, 723-729DOI: (10.1016/j.cmi.2017.03.024) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.